|
The King Hussein Cancer Center (KHCC) (Arabic مركز الملك حسين للسرطان),〔(),.〕 is a medical center in Amman, Jordan. It treats both adult and pediatric patients. KHCC treats over 3500 new cancer patients every year from Jordan and the region. KHCC has established programs that focus on all stages of comprehensive cancer care: from prevention and early detection, through diagnosis and treatment, to palliative care. The King Hussein Cancer Foundation (KHCF), founded in 1997, undertakes various fundraising activities to support and maintain the mission of KHCC as a comprehensive cancer center of excellence. KHCF is a free-standing, independent, non-governmental, nonprofit organization established by a royal decree to combat cancer in Jordan and the Middle East region. The foundation and center is run by a board of trustees consisting of a dedicated group of prominent volunteers and chaired by HRH Princess Ghida Talal. The director general of KHCF is HRH Princess Dina Mired and Dr. Asem Mansour is the director general of KHCC.〔()〕 ==History== Prior to the mid-1980s, there was no infrastructure for treating cancer patients in Jordan. For quality care, wealthy patients sought treatment abroad, while those without means were treated locally, with limited resources and poor results. In 1997, the Al-Amal Center, meaning "The Center of Hope", opened its doors. This much-needed cancer-specific hospital was established to provide the many patients in Jordan with quality care comparable to that offered in the West. To honor the late King Hussein, who had died of cancer, the center was renamed the King Hussein Cancer Center in 2002. From 2002-2006, the hospital intensely focused on areas of quality control, and the recruitment of highly qualified staff. Patients, patient services, programs and staff exponentially increased at a rapid pace. The focus, from its inception, was to deliver the highest level of care in a safe environment. In 2006, Mahmoud Sarhan became the director general and CEO of the King Hussein Cancer Center. Dr. Sarhan, a former professor of pediatrics in the Bone Marrow and Stem Cell Transplantation Program at Duke University, was an instrumental figure in the center’s establishment. He founded KHCC's bone marrow transplantation (BMT) program in 2003, a program which has become one of the largest and most successful BMT programs in the Middle East. It is one of the largest (performing approximately 100 bone marrow transplants each year) and most successful programs in the Middle East, achieving cure rates compatible with international standards. The program oversees both matched allogeneic and autologous transplants and performs transplants utilizing cord blood, making it the only program in Jordan and the second in the region that offers such a highly specialized procedure. Other non-cancer cases are also treated through the KHCC BMT program including thalassemia, aplastic anemia and other metabolic diseases. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「King Hussein Cancer Center」の詳細全文を読む スポンサード リンク
|